Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 6 45-6, 1999, Pages

  Gebremedhin, Debebe ^a   Lange, Andrew R ^a   Campbell, William B ^a   Hillard, Cecilia J ^a,b   Harder, David R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Dept of Pharmacol and Toxicology ^*  (United States)

Author keywords

Anandamide; Patch clamp; SR 141716A; Vasodilation; Whole cell; WIN 55,2121 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CALCIUM CHANNEL; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; COMPLEMENTARY DNA; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; RIMONABANT;

ANIMAL CELL; ARTERY TONE; ARTICLE; BRAIN ARTERY; CALCIUM CURRENT; CALCIUM TRANSPORT; CAT; DRUG EFFECT; FEMALE; GENE EXPRESSION; MALE; MUSCLE FUNCTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASODILATATION;

EID: 0033002210     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.6.h2085     Document Type: Article

References (45)

1. Alborch, E., J. B. Salom, and G. Torregrosa. Calcium channels in cerebral arteries. Pharmacol. Ther. 68: 1-34, 1995.
2. Catterall, W. Functional subunit structure of voltage-gated calcium channels. Science 242: 50-61, 1988.
3. 2+ current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br. J. Pharmacol. 106: 231-232, 1992.
4. Clapham, D. E., and E. J. Neer. G protein beta subunits. Annu. Rev. Pharmacol. Toxicol. 37: 167-203, 1997.
5. Deadwyler, S. A., R. E. Hampson, J. Mu, A. Whyte, and S. Childers. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurones via cAMP-dependent process. J. Pharmacol. Exp. Ther. 273: 734-743, 1995.
6. Deutsch, D. G., M. S. Goligorsky, P. C. Schmid, R. J. Krebsbach, H. H. O. Schmid, S. K. Das, S. K. Dey, G. Arreaza, C. Thorup, G. Stefano, and L. C. Moore. Production and physiological actions of anandamide in the vasculature of the rat kidney. J. Clin. Invest. 100: 1538-1546, 1997.
7. Devane, W. A., L. Hanus, A. Breuer, R. G. Pertwee, L. A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, and R. Mechoulam. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949, 1992.
8. Dolphin, A. C., and R. H. Scott. Interaction between calcium channel ligands and guanine nucleotides in cultured rat sensory and sympathetic neurones. J. Physiol. (Lond.) 413: 271-288, 1989.
9. 9-THC dilation of cerebral arterioles is blocked by indomethacin. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1859-H1864, 1995.
10. Gaoni, Y., R., and R. Mechoulam. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86: 1646-164, 1964.
11. 2+ current. J. Physiol. (Lond.) 507: 771-781, 1998.
12. Gerard, C. M., C. Mollereau, G. Vassart, and M. Parmentier. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279: 129-134, 1991.
13. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100, 1981.
14. Hansen, H. S., L. Lauritzen, A. M. Strand, A. M. Vinggaard, A. Frandsen, and A. Schousboe. Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons. J. Neurochem. 69: 753-761, 1997.
15. 2+ currents in cerebral neurons: persistent block of L-type channels by a pertussis toxin-sensitive G-protein. J. Neurosci. 13: 1148-1156, 1993.
16. Henry, D. J., and C. Chavkin. Activation of inwardly rectifying potassium channels (GIRK 1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci. Lett. 186: 91-94, 1995.
17. Hescheler, J., and G. Schultz. Heterotrimeric G proteins involved in the modulation of voltage-dependent calcium channels of neuroendocrine cells. Ann. NY Acad. Sci. 733: 306-312, 1994.
18. Howlett, A. C. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27: 429-436, 1985.
19. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29: 307-313, 1986.
20. Kempe, K., F. F. Hsu, A. Bohrer, and J. Turk. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue. J. Biol. Chem. 271: 17287-17295, 1996.
21. Lake, K. D., B. R. Martin, G. Kunos, and K. Varga. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29: 1204-1210, 1997.
22. Mackie, K., W. A. Devane, and B. Hille. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44: 498-503, 1993.
23. Mackie, K., and B. Hille. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89: 3825-3829, 1992.
24. Mackie, K., Y. Lai, R. Westenbroek, and R. Mitchell. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15: 6552-6561, 1995.
25. Mathew, R. J., and W. H. Wilson. Acute changes in cerebral blood flow after smoking marijuana. Life Sci. 52: 757-767, 1993.
26. Matsuda, L. A., S. J. Lolait, M. J. Brownstein, A. C. Young, and T. I. Bonner. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
27. Munro, S., K. L. Thomas, and M. Abu-Shaar. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65, 1993.
28. 2+ channels in a neuronal expression system. Mol. Pharmacol. 49: 707-714, 1996.
29. Plane, F., M. Holland, G. J. Waldron, C. J. Garland, and J. P. Boyle. Evidence that anandamide and EDHF act via different mechanism in rat isolated mesenteric arteries. Br. J. Pharmacol. 121: 1509-1511, 1997.
30. Pratt, P. F., C. J. Hillard, W. S. Edgemond, and W. B. Campbell. N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am. J. Physiol. 274 (Heart Circ. Physiol. 43): H375-H381, 1998.
31. Randall, M. D., S. P. H. Alexander, T. Bennett, E. A. Boyd, J. R. Fry, S. M. Gardiner, P. A. Kemp, A. I. McCulloch, and D. A. Kendall. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem. Biophys. Res. Commun. 229: 114-120, 1996.
32. Reuter, H. Calcium channel modulation by neurotransmitter, enzymes, and drugs. Nature 301: 569-574, 1993.
33. Rinaldi-Carmona, M., F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinex, J. Maruani, G. Neliat, D. Caput, P. Ferrara, P. Soubrie, J. C. Breliere, and G. LeFur. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350: 240-244, 1994.
34. Schmid, P. C., R. J. Krebsbach, S. R. Perry, T. M. Dettmer, J. L. Maasson, and H. H. O. Schmid. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375: 117-120, 1995.
35. Shen, M. X., T. M. Piser, V. S. Seybold, and S. A. Thayer. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16: 4322-4334, 1996.
36. 9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-y1)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H- pyrazole-3-carboximide hydrochloride], Biochem. Pharmacol. 51: 669-676, 1996.
37. Somlyo, A. P., and A. V. Somlyo. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994.
38. Stein, E. A., S. A. Fuller, W. S. Edgemond, and W. B. Campbell. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br. J. Pharmacol. 119: 107-114, 1996.
39. Strandgaard, S., and O. B. Paulson. Regulation of cerebral blood flow in health and disease. J. Cardiovasc. Pharmacol. 19, Suppl. 6: S89-S93, 1992.
40. Twitchell, W., S. Brown, and K. Mackie. Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78: 43-50, 1997.
41. Varga, K., K. D. Lake, D. Huangfu, P. G. Guyenet, and G. Kunos. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28: 682-686, 1996.
42. Varga, K., K. Lake, B. R. Martin, and G. Kunos. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur. J. Pharmacol. 278: 279-283, 1995.
43. Wagner, J. A., K. Varga, E. F. Ellis, B. A. Rzigalinski, B. R. Martin, and G. Kunos. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 390: 518-521, 1997.
44. White, R., and C. R. Hiley. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br. J. Pharmacol. 122: 1573-1584, 1997.
45. Zygmunt, P. M., E. D. Hogestatt, K. Waldeck, G. Edwards, A. J. Kirkup, and A. H. Weston. Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol. 122: 1679-1686, 1997.